DAFNA Capital Management »

Adicet Bio Ord shares owned by DAFNA Capital Management

Quarter-by-quarter ownership of Adicet Bio Ord (ACET) shares owned by DAFNA Capital Management from 13F filings

Historical chart of DAFNA Capital Management investment in Adicet Bio Ord

Tip: Access up to 7 years of quarterly data

All positions including Adicet Bio Ord held by DAFNA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adicet Bio Ord by DAFNA Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $790k 94k 8.42

More positions owned by DAFNA Capital Management

Revolution Medicines (RVMD)
Spdr S&p Biotech Etf Etf (XBI)
Stereotaxis Com New (STXS)
AtriCure (ATRC)
Cytokinetics Com New (CYTK)
Ideaya Biosciences (IDYA)
Axogen (AXGN)
Xenon Pharmaceuticals (XENE)
Ishares Nasdaq Biotech Indx Etf (IBB)
Biohaven (BHVN)
Arcus Biosciences Incorporated (RCUS)
Neurocrine Biosciences (NBIX)
Day One Biopharmaceuticals I (DAWN)
Tandem Diabetes Care Com New (TNDM)
Ascendis Pharma A/s Sponsored Adr (ASND)

View all positions for DAFNA Capital Management

Top funds holding Adicet Bio Ord

OrbiMed Advisors
RA Capital Management
Franklin Resources
Woodline Partners
Vanguard Group
Adage Capital Partners GP
Prosight Management
Renaissance Technologies
Goldman Sachs Group
Stonepine Capital Management
Alyeska Investment Group
Carlyle
Acadian Asset Management
Two Sigma Investments
ADAR1 Capital Management

View all funds holding Adicet Bio Ord